Health Policy spans our work with pharmaceuticals, medical devices and diagnostics from both a funding and access perspective. WestPAR has substantial experience in working collaboratively with governments in Western Canada to shift and reconfigure Policy to meet the emerging needs and realities of our evolving healthcare system.
Private and Provincial funding markets for pharmaceuticals, medical devices and diagnostics continue to rapidly evolve in response to concerns over balancing long-term sustainability, fiscal responsibility, therapeutic gaps, innovation, and increasing therapeutic options in rare diseases. WestPAR has the understanding, knowledge and skill set required to help you achieve your goals in Western Canada.
Innovation often creates new system challenges and barriers to access and funding. Having an experienced partner is critical to developing the appropriate strategy, acquiring guidance, and building collaborative consensus with government decision and policy makers.
• pCPA Engagement Strategy Western Perspective
• pCPA Negotiations with Western Lead Provinces
• Budget Impact Analysis (BIA) Modelling
• pCPA specific BIA Modeling
• Market Impact Modeling
• Environmental Scans
•PMPRB Pricing Strategy
•CDR Submissions (CAT I + II)
pCPA Strategy Negotiations
•Pharmacoeconomic Studies + Analysis
•Ontario + Quebec Specific Access, Funding and Policy Issues
